- Home
- MRNA vs TXRH Comparison
MRNA vs TXRH Comparison
Compare MRNA & TXRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | TXRH |
|---|---|---|
| Founded | 2010 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 11.0B |
| IPO Year | 2018 | 2004 |
Fundamental Metrics
Financial Performance| Metric | MRNA | TXRH |
|---|---|---|
| Price | $40.11 | $181.98 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 18 |
| Target Price | $31.09 | ★ $193.78 |
| AVG Volume (30 Days) | ★ 13.7M | 840.3K |
| Earning Date | 02-13-2026 | 02-19-2026 |
| Dividend Yield | N/A | ★ 1.48% |
| EPS Growth | N/A | ★ 12.56 |
| EPS | N/A | ★ 6.55 |
| Revenue | $2,232,000,000.00 | ★ $5,833,958,000.00 |
| Revenue This Year | N/A | $11.89 |
| Revenue Next Year | $6.38 | $10.50 |
| P/E Ratio | ★ N/A | $27.99 |
| Revenue Growth | N/A | ★ 14.40 |
| 52 Week Low | $22.28 | $148.73 |
| 52 Week High | $55.20 | $199.99 |
Technical Indicators
Market Signals| Indicator | MRNA | TXRH |
|---|---|---|
| Relative Strength Index (RSI) | 46.93 | 46.90 |
| Support Level | $36.66 | $184.89 |
| Resistance Level | $45.50 | $192.00 |
| Average True Range (ATR) | 3.09 | 5.33 |
| MACD | -1.07 | -0.99 |
| Stochastic Oscillator | 19.45 | 24.71 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About TXRH Texas Roadhouse Inc.
Texas Roadhouse Inc is a restaurant company operating predominantly in the casual dining segment. The company manages its restaurant and franchising operations by concept and, as a result, has identified Texas Roadhouse, Bubba's 33, Jaggers, and retail initiatives as separate operating segments. In addition, it has identified Texas Roadhouse and Bubba's 33 as reportable segments. Maximum revenue for the company is generated from the Texas Roadhouse segment, which is a moderately priced, full-service, casual dining restaurant concept offering steaks, a selection of ribs, seafood, chicken, pork chops, pulled pork, vegetable plates, and an assortment of hamburgers, salads, and sandwiches.